Preview

Drug development & registration

Advanced search

THE ROLE OF SMALL INNOVATIVE ENTERPRISES IN THE DEVELOPMENT AND MARKET LAUNCH OF INNOVATIVE DRUGS

Abstract

The features of new products market launch by small innovative enterprises are the theme for careful study. The reason is the problems that Russia has nowadays - the need for reindustrialization, the economic diversification and the import substitution for improving the competitiveness of domestic producers, the necessity for increase of real employment, the reduction of qualified personnel’s leak. It acquires special relevance in the pharmaceutical industry as it is one of the most high-technology industries. The innovative small and medium-sized enterprises (SME) could play a big role in solving these problems, as they could initiate innovations, lead (alone or in a partnership with larger companies) high-technology research and development, promote the commercialization of innovations.

About the Authors

A. A. Semin
Federal State Budgetary Educational Institution of Higher Education «St. Petersburg State Chemical Pharmaceutical Academy» of the Ministry of Healthcare of the Russian Federation
Russian Federation


I. A. Narkevich
Federal State Budgetary Educational Institution of Higher Education «St. Petersburg State Chemical Pharmaceutical Academy» of the Ministry of Healthcare of the Russian Federation
Russian Federation


References

1. Учет и мониторинг малых инновационных предприятий научно-образовательной сферы. URL: https://mip.extech.ru/ (дата обращения 23.12.2016).

2. Письмо Минэкономразвития России от 23.12.2016 г. № 39789-ОФ/Д01и.

3. Постановление Правительства РФ от 1 октября 2015 г. № 1045 «Об утверждении Правил предоставления субсидий из федерального бюджета российским организациям на возмещение части затрат на реализацию проектов по организации и проведению клинических исследований лекарственных препаратов в рамках подпрограммы «Развитие производства лекарственных средств» государственной программы Российской Федерации «Развитие фармацевтической и медицинской промышленности» на 2013-2020 годы».

4. Письмо Минобрнауки России от 23.08.2016 г. № 1222/14.

5. Horizonʼs 2020 SME Instrument // European Commission. Executive Agency for SMEs. 2015. URL: http://ec.europa.eu (дата обращения 27.12.2016).

6. SBIR/STTR. Frequently Asked Questions - General Questions // SBIR/STTR Americaʼs Seed Fund. 2015. URL: http://www.sbir.gov (дата обращения 27.12.2016).

7. Fast Track to Innovation pilot (2015-2016) // European Commission. 2015. URL: http://ec.europa.eu (дата обращения 27.12.2016).


Review

For citations:


Semin A.A., Narkevich I.A. THE ROLE OF SMALL INNOVATIVE ENTERPRISES IN THE DEVELOPMENT AND MARKET LAUNCH OF INNOVATIVE DRUGS. Drug development & registration. 2017;(1):206-211. (In Russ.)

Views: 579


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2305-2066 (Print)
ISSN 2658-5049 (Online)